IMVT
Immunovant Inc
33.30$
-2.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | |
| – | -83.4% | +10.3% | +25.0% | +11.3% | +11.2% | -19.2% | +33.7% | -1.9% | -3.8% | – | – | – | |
| – | – | – | -105.6% | – | – | – | -233.8% | – | – | – | – | – | |
| – | +0.8% | +36.7% | +14.3% | +28.9% | -2.8% | -0.9% | +8.1% | +12.9% | -13.4% | +43.8% | +0.2% | – | |
| – | -4.5% | +12.2% | +26.9% | -1.8% | +7.1% | +2.0% | +29.0% | -32.7% | -11.8% | +11.8% | +2.5% | – | |
| – | -0.4% | +31.4% | +16.6% | +22.8% | -1.2% | -0.4% | +11.8% | +3.6% | -13.2% | +39.5% | +0.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -123.8% | – | -66.8% | +1.3% | +94.9% | +283.6% | +56.6% | -34.9% | +161.3% | -283.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.